Roots of Rumex abyssinicus lower blood sugar, can be used for diabetes treatment: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-09-15 04:15 GMT   |   Update On 2022-09-15 08:27 GMT

Ethiopia: Findings from a recent study, published in the Evidence-Based Complementary and Alternative Medicine, have supported the traditional use of Rumex abyssinicus roots for the treatment of diabetes mellitus. The study showed that the crude extract of the plant owned antidiabetic activity. Diabetes Mellitus is a chronic disease that required long-lasting treatment. Several plants have...

Login or Register to read the full article

Ethiopia: Findings from a recent study, published in the Evidence-Based Complementary and Alternative Medicine, have supported the traditional use of Rumex abyssinicus roots for the treatment of diabetes mellitus. The study showed that the crude extract of the plant owned antidiabetic activity. 

Diabetes Mellitus is a chronic disease that required long-lasting treatment. Several plants have been used for treating diabetes for a long period in Ethiopian traditional medicine practices. Ethiopians have used the root of Rumex abyssinicus for the treatment of diabetes mellitus.

Against the above background, Getaye Tessema Desta, Debre Tabor University, Debre Tabor, Ethiopia, and aimed to investigate the antidiabetic activity of the crude extract of Rumex abyssinicus root in Swiss albino mice. 

For crude extraction, the cold maceration technique and hydro methanolic (80% methanol) solvent with occasionally shaking were employed. Normoglycemic, glucose-loaded, and streptozotocin-induced diabetic models were used to evaluate the antidiabetic activity of the crude extract. In each model, the mice who were fasted overnight were randomly divided into five groups for normoglycemic and glucose-loaded models negative control, positive control, and three tested groups. In streptozotocin-induced diabetic models, the mice were grouped into six groups like one diabetic and one normal negative control group, three diabetic tested groups, and one diabetic positive group.

Each group consisted of six mice. For all models, the tested groups received the crude extract at 100, 200, and 400 mg/kg doses. Both both diabetic and nondiabetic negative control groups received 10 ml/kg distilled water, and positive groups received 5 mg/kg glibenclamide. 

Based on the study, the researchers reported the following findings:

  • The crude extract of the plant did not show any sign of toxicity up to 2000 mg/kg dose.
  • In normoglycemic and oral glucose tolerance tests, the crude extract significantly reduced the blood glucose level at 200 and 400 mg/kg doses.
  • In the streptozotocin-induced diabetes models, a significant effect was observed at all tested doses.

"We found that Hydromethanolic crude extract of the root of R. abyssinicus has significant glucose-lowering activity both in normal and STZ-induced diabetic mice," the researchers wrote. "This study confirms that the root part of R. abyssinicus posees antidiabetic activity and supports the use of the root for diabetes treatment." 

They concluded by saying that, the higher dose of the root part of the plant demonstrated a significant blood glucose-reducing activity. Based on the acute oral toxicity study, the study plant showed a wide margin of safety."

Reference:

Baye Yrga Adugna, Getinet Mequanint Adinew, Kefyalew Ayalew Getahun, Abyot Endale Gurmu, Alemshet Yirga Berhie, Tewachew Awoke, Getaye Tessema Desta, "Evaluation of the Antidiabetic Activity of Hydromethanolic Roots Extracts of Rumex abyssinicus Jacq: (Polygonaceae) in Swiss Albino Mice", Evidence-Based Complementary and Alternative Medicine, vol. 2022, Article ID 5193250, 11 pages, 2022. https://doi.org/10.1155/2022/5193250

Tags:    
Article Source : Evidence-Based Complementary and Alternative Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News